18
Mar

MD Anderson’s popular “moon-shot” immuno-oncology research project has won over another big industry player looking to play catch-up in the hottest race in cancer drug R&D. AstraZeneca’s biologics arm, MedImmune, has become the latest Big Pharma player to join a team that has already attracted Pfizer and J&J.

…read more

Source: AstraZeneca signs up for MD Anderson’s ‘moon-shot’ immuno-oncology project

    

0 No comments